p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis

被引:382
作者
Rocco, JW
Leong, CO
Kuperwasser, N
DeYoung, MP
Ellisen, LW [1 ]
机构
[1] Massachusetts Gen Hosp, Canc Res Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Div Surg Oncol, Boston, MA 02114 USA
[4] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
关键词
D O I
10.1016/j.ccr.2005.12.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We demonstrate that Delta Np63 alpha is an essential survival factor in head and neck squamous cell carcinoma (HNSCC) through its ability to suppress p73-dependent apoptosis. Inhibition of endogenous p63 expression by RNAi induces apoptosis selectively in HNSCC cells that overexpress Delta Np63 alpha. Knockdown of p63 induces the proapoptotic bcl-2 family members Puma and Noxa, and both their induction and subsequent cell death are p53 independent but require transactivating isoforms of p73. Inhibition of p73-dependent transcription by Delta Np63 alpha involves both direct promoter binding and physical interaction with p73. In HNSCC cells lacking endogenous Delta Np63 alpha expression, bc1-2 is instead upregulated and can suppress p73-mediated death. Together, these data define a pathway whereby Delta Np63 alpha promotes survival in squamous epithelial malignancy by repressing a p73-dependent proapoptotic transcriptional program.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 59 条
[1]   IGFBP-3 is a direct target of transcriptional regulation by ΔNp63α in squamous epithelium [J].
Barbieri, CE ;
Perez, CA ;
Johnson, KN ;
Ely, KA ;
Billheimer, D ;
Pietenpol, JA .
CANCER RESEARCH, 2005, 65 (06) :2314-2320
[2]   p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis [J].
Bergamaschi, D ;
Gasco, M ;
Hiller, L ;
Sullivan, A ;
Syed, N ;
Trigiante, G ;
Yulug, I ;
Merlano, M ;
Numico, G ;
Comino, A ;
Attard, M ;
Reelfs, O ;
Gusterson, B ;
Bell, AK ;
Heath, V ;
Tavassoli, M ;
Farrell, PJ ;
Smith, P ;
Lu, X ;
Crook, T .
CANCER CELL, 2003, 3 (04) :387-402
[3]  
Bjorkqvist AM, 1998, GENE CHROMOSOME CANC, V22, P79
[4]   Tissue-specific inactivation of p53 tumor suppression in the mouse [J].
Bowman, T ;
Symonds, H ;
Gu, LY ;
Yin, CY ;
Oren, M ;
VanDyke, T .
GENES & DEVELOPMENT, 1996, 10 (07) :826-835
[5]   How many mutant p53 molecules are needed to inactivate a tetramer? [J].
Chan, WM ;
Siu, WY ;
Lau, A ;
Poon, RYC .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (08) :3536-3551
[6]   Hypermethylation of gene promoters in hematological neoplasia [J].
Chim, CS ;
Liang, R ;
Kwong, YL .
HEMATOLOGICAL ONCOLOGY, 2002, 20 (04) :167-176
[7]   Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis [J].
Choi, HR ;
Batsakis, JG ;
Zhan, F ;
Sturgis, E ;
Luna, MA ;
El-Naggar, AK .
HUMAN PATHOLOGY, 2002, 33 (02) :158-164
[8]   p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53 [J].
Davison, TS ;
Vagner, C ;
Kaghad, M ;
Ayed, A ;
Caput, D ;
Arrowsmith, CH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18709-18714
[9]   The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells [J].
Ellisen, LW ;
Carlesso, N ;
Cheng, T ;
Scadden, DT ;
Haber, DA .
EMBO JOURNAL, 2001, 20 (08) :1897-1909
[10]   Tumor predisposition in mice mutant for p63 and p73:: Evidence for broader tumor suppressor functions for the p53 family [J].
Flores, ER ;
Sengupta, S ;
Miller, JB ;
Newman, JJ ;
Bronson, R ;
Crowley, D ;
Yang, A ;
McKeon, F ;
Jacks, T .
CANCER CELL, 2005, 7 (04) :363-373